Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Exelixis, Inc.(EXEL) | 1,899,151 | 1,899,079 | -72 | $41.5K | $45.6K | 16.16% | +$4.1K |
| United Therapeutics Corporation(UTHR) | 201,222 | 200,872 | -350 | $45.5K | $44.2K | 15.67% | -$1.3K |
| Biogen Inc.(BIIB) | 160,480 | 160,480 | 0 | $41.2K | $41.5K | 14.73% | +$282 |
| Regeneron Pharmaceuticals, Inc.(REGN) | 47,256 | 47,256 | 0 | $38.9K | $41.5K | 14.73% | +$2.6K |
| Cardinal Health, Inc.(CAH) | 291,319 | 281,476 | -9,843 | $25.3K | $28.4K | 10.07% | +$3.1K |
| Taro Pharmaceutical Indus | 640,735 | 646,453 | +5,718 | $24.2K | $27.0K | 9.58% | +$2.8K |
| Alkermes plc(ALKS) | 906,060 | 918,038 | +11,978 | $25.4K | $25.5K | 9.04% | +$87 |
| Jazz Pharmaceuticals plc(JAZZ) | 0 | 100,000 | +100,000 | $0 | $12.3K | 4.36% | +$12.3K |
| Sanofi(SNY) | 0 | 150,400 | +150,400 | $0 | $7.5K | 2.65% | +$7.5K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 735,103 | 742,824 | +7,721 | $8.2K | $7.0K | 2.48% | -$1.2K |
| Masimo Corp | 0 | 8,000 | +8,000 | $0 | $938 | 0.33% | +$938 |
| Mural Oncology Plc | 0 | 90,833 | +90,833 | $0 | $538 | 0.19% | +$538 |
| EAGLE PHARMACEUTICALS INCCOM | 112,666 | 0 | -112,666 | $1.8K | $0 | — | -$1.8K |
| EMBECTA CORPCOM(EMBC) | 1,164,876 | 0 | -1,164,876 | $17.5K | $0 | — | -$17.5K |
| KODIAK SCIENCES INCCOM(KOD) | 342,312 | 0 | -342,312 | $616 | $0 | — | -$616 |
| VANDA PHARMACEUTICALS INCCOM(VNDA) | 360,429 | 0 | -360,429 | $1.6K | $0 | — | -$1.6K |